Company number: 04620455 Registered Charity: 1099537 European Society for Clinical Virology (Limited by guarantee) Report and Financial Statements for the year ended 31 October 2025 17/07/2026 Page 1 of 10 European Society for Clinical Virology (Limited by Guarantee) ## **Members of Executive - Company Directors (November 1[st] 2024 - October 31[st] 2025)** Prof. Dr. Pamela Vallely (President) Prof Dr. Mariet C.W. Feltkamp (Past President) Prof. Dr. Annelies Riezebos-Brilman(Vice President) Prof. Dr. Maria São José Alexandre Nascimento (Vice President) Prof. Dr. Catherine Moore (General Secretary) Prof. Dr. Xavier López-Labrador (Communication Officer) Prof. Dr. George Sourvinos (Treasurer) Prof. Dr. Heli Harvala (Meetings Secretary) ## **Company Secretary** Ester Zoroa, Kenes Group, KAM Page 2 of 10 European Society for Clinical Virology (Limited by Guarantee) ## **European Society for Clinical Virology (ESCV) details** Registered Office Charles Darwin House 12 Roger Street London Company limited by guarantee N° 04620455 Registered as a Charity in England N° 1099537 Inland Revenue reference: 610 94961 19846 A 01 Page 3 of 10 European Society for Clinical Virology (Limited by Guarantee) ## **Directors’ Report** The European Society for Clinical Virology (ESCV) is a Company Limited by Guarantee, first incorporated in 2003. In accordance with the Society’s Memorandum of Association, each Company Member undertakes to contribute such amount as may be required, not exceeding £1, to the Company’s assets if it should be wound up while he or she is a Company Member or within one year after he or she ceases to be so. The Society is registered as a Charity, the Company Directors being the Charity’s Trustees. The Company Directors acting collectively are the Society’s Executive. The Executive hereby submits its report and financial statements for the year ending October 31[st] , 2025. ## _**Organization and Objectives**_ According to the articles, the Society is administered by the Executive, made up of minimum three and maximum ten Company Directors/Charity Trustees. Currently the Executive numbers eight Directors. The ESCV has appointed a professional secretariat to handle administrative matters. This secretariat is Kenes Group, Rue François-Versonnex 7, 1207 Geneva, Switzerland. In accordance with Article 4 the Executive admits as ‘ESCV Members’ such persons and subjects them to such rights and obligations as it thinks fit. Such ‘ESCV Members’ are not Company Members for the purposes of the Articles and are not entitled to vote on any matter save where expressly provided in the Articles. ESCV members of different European and other countries are represented by councilors, elected by each country’s members according to procedures described in the Articles. The councilors acting collectively are the Council. The Council elects the Company Directors/Charity Trustees according to procedures described in the Articles. The Society’s objectives are to promote public health and to advance public education, in particular medical education, by: - improving the knowledge of viruses, particularly as it relates to the diagnosis and management of viral diseases, their pathogenesis, natural history and prevention. - improving diagnostic methods. - promoting high standards in laboratory viral diagnosis through quality assessment activities and education; and - promoting or developing for the benefit of the public the preparation and exchange of reference reagents. ## _**Reserves Policy**_ The Executive has the policy to maintain sufficient funds to allow the Society to meet its objectives and obligations on a long-term basis, and to provide a measure of investment income. It is the objective of the Society to utilize fully each year’s net income for its charitable activities. Page 4 of 10 European Society for Clinical Virology (Limited by Guarantee) ## _**Review of Activities in 2024/2025**_ ## **Scientific Meetings** - ESCV – ENPEN Workshop European Non – Polio Enterovirus Network, 16-17 September 2025, Thessaloniki, Greece - ESCV – ENNGS workshop, 16-17 September 2025; Thessaloniki, Greece - 27th ESCV Conference, Thessaloniki (Greece) - 17-20 September 2025 ## **Awards given at the 27[th ] Annual Conference of the European Society for Clinical Virology 2025 (Thessaloniki)** - European Diagnostic Virology (former Abbott Award) 2025 to Koen Vercauteren (Belgium) - BioMerieux Award 2025 to William Irving (UK) - Gardner Lectureship Award 2025 to Florian Krammer (Austria) - Heine-Medin Award 2025 to Siddharth Sridhar (Hong Kong, China) ## **Travel grants and fellowships given** - 21 virologists received a grant to attend the 27[th] Annual Conference of the European Society for Clinical Virology ## **Training grants** - None ## **Business Meetings held** - ESCV Executive Meetings were held on 23[rd] of January, 27[th] of February, 27[th] of March, 24[th] of April, 29[th] of May, 26[th] of June, 11[th ] and 31[st] of July, 28[th] of August, 16[th] of September, 30[th] of October, 27[th] of November and 18[th] of December 2025. - Council Meeting was held on 18[th] of September 2025 - General Assembly was held on 19[th] of September 2025. Page 5 of 10 European Society for Clinical Virology (Limited by Guarantee) ## **Future Scientific Meetings planned** - 28[th] Annual Conference of the ESCV, 16[th] – 19[th] of September 2026 (Porto, Portugal). ------------------------------------------------------------ Signed on behalf of the Executive (Company Directors), Prof. Heli Harvala Company President Page 6 of 10 European Society for Clinical Virology (Limited by Guarantee) ## **Statement of financial activities (incorporating the income and expenditure account) Year ended 31 0ctober 2025** Page 7 of 10 European Society for Clinical Virology (Limited by Guarantee) Page 8 of 10 European Society for Clinical Virology (Limited by Guarantee) ## **Audit Exemption** - (a) For the year ended 31 October 2025 the company was entitled to exemption from audit under section 477(2) of the Companies Act 2006 relating to small companies. - (b) Members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006. - (c) The directors acknowledge their responsibility for: - i. ensuring the company keeps accounting records which comply with section 386; and ii. preparing accounts which give a true and fair view of the state of affairs of the company as at the end of the financial year, and of its profit or loss for the financial year, in accordance with the requirements of section 393, and which otherwise comply with the requirements of the Companies Act relating to accounts, so far as applicable to the company. (d) These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies’ regime. **Approved by Executive on 16 of May 2026 and signed on its behalf by Prof. Heli Harvala (Company President).** Prof. Heli Harvala **Company President** Page 9 of 10 European Society for Clinical Virology (Limited by Guarantee) This page is left blank intentionally (last page) Page 10 of 10 ## **EUROPEAN SOCIETY FOR CLINICAL VIROLOGY, LONDON** ## **Balance sheet accounts as at October 31, 2025** |Notes
**ASSETS**
Bank account
4
Debtor ECCI
Accounts receivable
**LIABILITIES**
Accounts payable
**GENERAL RESERVES**
General reserves brought forward
Result of the year
Foreign exchange conversion|**2025**
**EUR**
31’689
9’998
13’284
**54’971**
1’212
**1’212**
32’758
21’001
-
**53’759**
**54’971**|**2025**
**GBP**
_0.87977_
27’879
8’796
11’687
**48’362**
1’066
**1’066**
27’330
18’476
1’490
**47’296**
**48’362**|**2024**
**EUR**
26’529
6’392
-
**32’921**
163
**163**
174’036
-141’278
-
**32’758**
**32’921**|**2024**
**GBP**
0.83430
22’133
5’333
-
**27’466**
136
**136**
151’823
-117’868
-6’625
**27’330**
**27’466**| |---|---|---|---|---| Digitally signed by Heli Harvala Heli DN: cn=Heli Harvala, c=FI, email=heli.harvala@utu.fi Harvala Date: 2026.05.16 21:36:05+03'00' Authorized signature Authorized signature Date _______________________________ The notes to the accounts form part of these financial statements Page 2 ## **EUROPEAN SOCIETY FOR CLINICAL VIROLOGY, LONDON Income & Expenses accounts from 1 November 2024 to 31 October 2025** |Notes
**INCOMES**
Membership fees
Sponsorship
Congress income
5
**EXPENSES**
Travel grants
Awards
Workshop expenses
Project expenses
Journal expenses
Administrative expenses
Bank charges
Extraordinary expenses
6
**Net gain/loss of the year**|**2025**
**2025**
**EUR**
**GBP**
0.87977
18’186
15’999
6’000
5’279
46’137
40’590
**70’323**
**61’868**
13’879
12’210
6’017
5’294
377
332
-
-
1’105
972
26’311
23’147
1’633
1’437
-
-
**49’322**
**43’392**
**21’001**
**18’476**|**2024**
**2024**
**EUR**
**GBP**
0.83430
24’490
20’432
10’500
8’760
37’669
31’427
**72’659**
**60’619**
51’546
43’005
10’500
8’760
89’340
74’536
24’342
20’309
1’755
1’464
27’640
23’060
3’814
3’182
5’000
4’171
**213’937**
**178’487**
**-141’278**
**-117’868**| |---|---|---| The notes to the accounts form part of these financial statements Page 3 CHARITY COMMISSION FOR ENGLAND AND WALES Independent examiner's report on the accounts Section A Independent Examinerfs Report Report to the trusteesl members of European Society for Clinical Wirology On accounts for the year ended 31" October 2025 Charity no (if any 1099537 Set out on pag8S I report to the trustees on my examination of the accounts of the above charity ('the Trust") for the year ended 3111012025. Responslbllltles and As the charity trustees of the Trust, you are responsible for the preparation basis of report of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act.). I report in respect of my examination of the Trust's accounts Carried out under section 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by th8 Charity Commission under section 14515)(bl of the Act. I have completed my examinalion. l ¢onfimi that no material matters have come to my attention (other than that dis¢losed below ") in connection with the examination which giv8s me cause to believe that in, any mat8ri81 respect.. accounting records were not kept In ac¢ordanc8 With s8Ction 130 of the Act or the accounts do not accord with th8 accounting records Independent examinerfs statement I have no COn￿rn$ and have come across no other matters in connection with the examination to which attention should be drawn in order to enable proper understanding of the accounts to be reached. 8 d818t8 th8 WO s in the brack8ts if they do not apply. Slgned: Date: Name: Relevant professional qualificatlon(sl or body (if any): C.H. G•urt• ¥•n K*￿¢1 Clinical viroloyist Department ¢fViroscienrAI Erasmus MC Rovierdam Address: IER October 2018 Section B Disclosure Only complete if the examiner needs to highlight matters of concern (see CC32, Independent examination of charity accounts.. directions and guidance for examiners). Give here brief details of any items that the examiner wishes to disclose. IER October 2018 CHARITY COMMISSION FOR ENGLAND AND WALES Independent examinerfs report on the accounts Section A Independent Examiner's Report Report to the trusteesl members of European Society for Clinical Virology On accounts for the year anded 3151 Octobèr 2025 Charlty no (if any 1099537 Set out on pages I report to the trustees on rny examination of the accounts of the above charity ('Ihe Trust") for the year ended 3111012026. Re8pon$lbllitles and As the charity trustees of the Trust, you are responsible for the preparation baslg of report of the accounts in accordan￿ with the requirements of the Charities Act 2011 (°the Act,). I report in respect of my examination of the Trust's accounts carried out under seclion 145 of the 2011 Act and in carrying out my examination, I have followed the applicable Directions given by the Charity Commission under section 145151{b) of the Act. I have completed my examination. I confimi that no matenal matters have come to my att8ntion {other than that disclosed below ') in connection with the examination which gives me cause to believe that in, any material respect- accounting records were not kept in accordance with section 130 of the Act or the accounts do not accord with the accounting records Indep•ndant 6xamlnor'8 statsmont I have no concems and have come across no other matters in connection with the examination to which attention should be drawn in order to enab18 proper un nding of the accounts to be reached. Ple8S to the words in the br8ckgts if Ihey do not apply. A2.05. £02 Signed: Dats: Name: 5E7f(]c/D /r*/ Relevant profosslonal qualification{sl or body {rfany): /0 fC£w, Address: IER Octobor 2018 Section 8 Disclosure Only complete ifthe examiner needs to highlight matters of concem (see CC32, Independent examination of charty accounts: directions and guidance for examiners). Give here bri8f datalls of any items that th? èxamlner wlshes to dlsclo80. IER October 2018